SCHEMBL217901

SCHEMBL217901

CS(=O)(=O)O.O=C1CCCC(=O)N1

nearest known ligand 0.65

Known targets — ChEMBL curated mechanism

ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 known ✓ P00519 1/20 0.33
CRBN Q96SW2 5/20 0.65
MAPT P10636 2/20 0.38
OR51E2 Q9H255 1/20 0.35
ALDH1A1 P00352 2/20 0.34
PKM P14618 1/20 0.34
CYP2C19 P33261 2/20 0.33
MEN1 O00255 1/20 0.33
TSHR P16473 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
FKBP5 Q13451 1/20 0.33
RIN1 Q13671 1/20 0.33
IDO1 P14902 1/20 0.31
KDM4E B2RXH2 1/20 0.30
LMNA P02545 1/20 0.30
TP53 P04637 1/20 0.30
TOP2A P11388 1/20 0.30
TOP2B Q02880 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Succinimide SCHEMBL216817 0.90 CRBN (0.61) CRBNMAPTALDH1A1PKMCYP2C19
Sulfuric Acid SCHEMBL6537451 0.90 CRBN (0.72) CRBNMAPTOR51E2ALDH1A1CYP2C19
Sulfuric Acid SCHEMBL5145399 0.90 CRBN (0.72) CRBNMAPTOR51E2ALDH1A1CYP2C19
Methyl Alcohol SCHEMBL28109851 0.84 CRBN (0.81) CRBNMAPTOR51E2ALDH1A1CYP2C19
SCHEMBL6537449 0.81 CRBN (0.59) CRBNMAPTOR51E2ALDH1A1FKBP5
SCHEMBL26618 0.81
SCHEMBL5778743 0.81 CRBN (1.00) CRBNMAPTOR51E2ALDH1A1CYP2C19
Succinimide SCHEMBL27863987 0.78 CRBN (0.69) CRBNPKM
Succinimide SCHEMBL30302994 0.78 CRBN (0.69) CRBNPKM
Ammonia Solution, Strong SCHEMBL10590100 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12258341-B2 IRAK degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2025-03-25 US disclosed
US-20240239777-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2024-07-18 US disclosed
CN-106094440-B Lower layer film for lithography forming material, lower layer film for lithography and pattern forming method 三菱瓦斯化学株式会社 2019-11-22 CN disclosed
CN-106062630-B Photopolymerizable compositions for electroless plating processes 伊斯曼柯达公司 2019-11-05 CN disclosed
CN-106459650-B Latex primer composition and latex primer coated substrate 伊斯曼柯达公司 2019-05-10 CN disclosed
CN-104281006-B Radiation-ray sensitive composition 三菱瓦斯化学株式会社 2019-01-22 CN disclosed
CN-106795384-A Carbon coated metallic particles, article and the purposes being dispersed through 柯达公司 2017-05-31 CN disclosed
CN-106575083-A Underlayer film-forming composition for lithography, underlayer film for lithography, and pattern forming method 三菱瓦斯化学株式会社 2017-04-19 CN disclosed
CN-106459650-A Latex primer composition and latex primer coated substrate 伊斯曼柯达公司 2017-02-22 CN disclosed
CN-106462072-A Lithographic film formation material, composition for lithographic film formation, lithographic film, pattern formation method, and purification method 三菱瓦斯化学株式会社 2017-02-22 CN disclosed
US-7214743-B2 Resist lower layer film material and method for forming a pattern SHIN-ETSU CHEMICAL CO., LTD. (JP) 2007-05-08 US disclosed
US-7189493-B2 Polymer, positive resist composition, and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2007-03-13 US disclosed
US-7169541-B2 Compound, polymer, resist composition, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2007-01-30 US disclosed
US-20060234158-A1 Bottom resist layer composition and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2006-10-19 US disclosed
US-20060147836-A1 Resist composition and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2006-07-06 US disclosed
US-20050079446-A1 Novel polymerizable compound, polymer, positive-resist composition, and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2005-04-14 US disclosed
US-20050079440-A1 Novel polymer, positive resist composition, and patterning process using the same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2005-04-14 US disclosed
US-20050014092-A1 Novel compound, polymer, resist composition, and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2005-01-20 US disclosed
US-20040259037-A1 Resist lower layer film material and method for forming a pattern SHIN-ETSU CHEMICAL CO., LTD. (JP) 2004-12-23 US disclosed
US-20040241577-A1 Resist lower layer film material and method for forming a pattern SHIN-ETSU CHEMICAL CO., LTD. (JP) 2004-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12258341-B2 IRAK degraders and uses thereof IRAK2, IRAK3, IRAK1 ABL1 521/4885CRBN 187/4885MAPT 2459/4885
US-20240239777-A1 IRAK DEGRADERS AND USES THEREOF IRAK2, IRAK3, IRAK1 ABL1 521/4885CRBN 187/4885MAPT 2459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.